These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6804679)

  • 21. Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.
    Griesbacher T; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1989 Jan; 96(1):236-42. PubMed ID: 2647203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids.
    Kapás L; Benedek G; Penke B
    Neuropeptides; 1989; 14(2):85-92. PubMed ID: 2812292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions of bombesin, thyrotropin releasing factor, prostaglandin E2 and naloxone on thermoregulation in the rat.
    Brown M; Rivier J; Vale W
    Life Sci; 1977 May; 20(10):1681-7. PubMed ID: 406488
    [No Abstract]   [Full Text] [Related]  

  • 24. Gastroprotection and control of food intake by leptin. Comparison with cholecystokinin and prostaglandins.
    Konturek PC; Konturek SJ; Brzozowski T; Hahn EG
    J Physiol Pharmacol; 1999 Mar; 50(1):39-48. PubMed ID: 10210153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive effect of cholecystokinin and its related peptides on beta-endorphin-induced catalepsy in rats.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Sep; 74(4):381-4. PubMed ID: 6271561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin and satiety in pigs.
    Anika SM; Houpt TR; Houpt KA
    Am J Physiol; 1981 May; 240(5):R310-8. PubMed ID: 6263113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin and thermoregulation.
    Bissette G; Luttinger D; Mason GA; Hernandez DE; Loosen PT
    Ann N Y Acad Sci; 1982; 400():268-82. PubMed ID: 6820243
    [No Abstract]   [Full Text] [Related]  

  • 28. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine.
    Collu R; Clermont MJ; Ducharme JR
    Eur J Pharmacol; 1976 May; 37(1):133-40. PubMed ID: 819277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of thyrotropin releasing hormone on pentobarbital tolerance.
    Bhargava HN
    Eur J Pharmacol; 1981 Jun; 72(1):63-8. PubMed ID: 6790297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of central and peripheral anorectic effects of caerulein by L-364,718.
    Leighton GE; Griesbacher T; Hill RG; Hughes J
    Eur J Pharmacol; 1989 Feb; 161(2-3):255-8. PubMed ID: 2721558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Nov; 75(4):313-6. PubMed ID: 6274669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
    Johnson LR; Guthrie P
    Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of scretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat.
    Dockray GJ
    J Physiol; 1972 Sep; 225(3):679-92. PubMed ID: 5076393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G
    Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
    Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
    Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of TRH and CCK in the satiation of alcohol intake.
    Kulkosky PJ; Wise VJ; Brandt SS; Chavez KJ
    Physiol Behav; 2004 Aug; 82(1):53-6. PubMed ID: 15234590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
    Smith GP; Jerome C; Kulkosky P; Simansky KJ
    Peptides; 1984; 5(6):1149-57. PubMed ID: 6099563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroanatomical dissociation of thyrotropin-releasing hormone induced shaking behavior and thermogenic mechanisms.
    Kalivas PW; Horita A
    Regul Pept; 1981 Feb; 1(5):335-45. PubMed ID: 6789407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of caerulein on pituitary response to TRH in humans.
    Scarpignato C; Pezzetta A; Tarditi E
    Horm Res; 1986; 24(4):295-301. PubMed ID: 3096866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.